Home › ForteBio Launches Dip And Read Anti-Human Fab-CH1 Biosensor To Accelerate Human Biotherapeutic Drug Development
 

Keywords :   


ForteBio Launches Dip And Read Anti-Human Fab-CH1 Biosensor To Accelerate Human Biotherapeutic Drug Development

2013-01-09 18:00:00| drugdiscoveryonline News Articles

ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, recently announced the launch of its Dip and Read Anti-Human Fab-CH1 biosensor

Tags: read development human drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 18
03.07Hurricane Beryl Wind Speed Probabilities Number 18
03.07Hurricane Beryl Public Advisory Number 18
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 18
03.07Hurricane Beryl Graphics
03.07Atlantic Tropical Weather Outlook
More »